The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

The a2 Milk Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $4.18 billion
P/E Ratio 29.55
Dividend Yield 0.00%
Shares Outstanding 724.02 million
Earnings per share 0.231
Dividend per share N/A
Year To Date Return 29.81%
Earnings Yield 3.38%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • The a2 Milk Co Ltd (ASX: A2M)
    Latest News

    a cute young girl with curly hair sips a glass of milk through a straw with a smile on her face.
    Share Market News

    The A2 Milk share price has smashed the ASX 200 over the past month. What's going on?

    The fresh milk and infant formula company looks to be turning things around after struggling with pandemic border closures.

    Read more »

    A man in a business suit holds a mobile phone to his ear while he drinks a large glass of milk.
    Opinions

    Why this expert acquired a thirst for A2 Milk shares following the company's latest results

    This fund manager is convinced by A2 Milk's turnaround strategy.

    Read more »

    A young girl and boy drinking milk in a garden setting
    Broker Notes

    A2 Milk shares: Buy, hold, or fold?

    Here's why one top broker thinks the milk and baby formula producer's stock could surge 21%.

    Read more »

    a happy dog puts its head out of a car window with a road in the background, indicating a positive share price for ASX automotive shares
    Consumer Staples & Discretionary Shares

    Could the A2 Milk share price be ready to leave the 'doghouse'?

    One expert says green shoots are starting to appear for this ASX share.

    Read more »

    Excited baby making a surprised happy face
    Share Market News

    Leading fund manager sees "material upside" to the a2 Milk share price

    Here's why one fund manager thinks the a2 Milk share price can go even higher.

    Read more »

    Broker looking at the share price on her laptop with green and red points in the background.
    Broker Notes

    Broker says the A2 Milk share price can charge even higher

    A2 Milk shares have been tipped as a buy...

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why A2 Milk, BHP, Lovisa, and Nickel Industries shares are charging higher

    These ASX shares are starting the week strongly...

    Read more »

    A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
    Consumer Staples & Discretionary Shares

    Why is the A2 Milk share price storming 6% higher on Monday?

    A2 Milk shares are rising again. Here's why...

    Read more »

    A man holds a Chinese flag and give the thumbs up, indicating approval for Chinese shares trading on US stock market
    Consumer Staples & Discretionary Shares

    A2 Milk share price on watch following China update

    A2 Milk's Chinese operations have received a boost...

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why A2 Milk, Life360, Nine, and Ramsay shares are dropping

    These ASX shares are ending the week in the red...

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Broker Notes

    Why is the A2 Milk share price tumbling lower today?

    A2 Milk's shares have taken a tumble on Friday. Here's why...

    Read more »

    Investor sitting in front of multiple screens watching share prices
    Share Market News

    5 things to watch on the ASX 200 on Friday

    The ASX 200 index is expected to have a strong day...

    Read more »

    Frequently Asked Questions

    The a2 Milk Company Ltd does not currently pay a dividend.

    The a2 Milk Company Ltd does not currently have a dividend reinvestment program.

    The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.

    A2M ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About The a2 Milk Co Ltd

    A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

    The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.

    The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

    A2M Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    31 Oct 2024 $5.77 $0.02 0.35% 1,983,122 $5.73 $5.84 $5.68
    30 Oct 2024 $5.75 $-0.08 -1.37% 1,646,474 $5.90 $5.91 $5.75
    29 Oct 2024 $5.83 $0.10 1.75% 5,071,981 $5.79 $5.98 $5.78
    28 Oct 2024 $5.73 $-0.01 -0.17% 1,772,557 $5.74 $5.78 $5.70
    25 Oct 2024 $5.74 $-0.07 -1.20% 2,052,391 $5.81 $5.83 $5.73
    24 Oct 2024 $5.81 $-0.12 -2.02% 1,320,827 $5.91 $5.92 $5.81
    23 Oct 2024 $5.93 $0.04 0.68% 3,776,607 $5.89 $5.97 $5.88
    22 Oct 2024 $5.89 $-0.02 -0.34% 2,269,247 $5.91 $5.95 $5.78
    21 Oct 2024 $5.91 $0.01 0.17% 1,965,189 $6.03 $6.07 $5.90
    18 Oct 2024 $5.90 $-0.09 -1.50% 3,213,583 $5.96 $5.97 $5.86
    17 Oct 2024 $5.99 $-0.15 -2.44% 2,146,714 $6.18 $6.21 $5.98
    16 Oct 2024 $6.14 $-0.22 -3.46% 2,449,936 $6.30 $6.33 $6.12
    15 Oct 2024 $6.36 $-0.06 -0.93% 2,167,316 $6.33 $6.40 $6.28
    14 Oct 2024 $6.42 $-0.03 -0.47% 777,670 $6.50 $6.52 $6.41
    11 Oct 2024 $6.45 $-0.01 -0.15% 1,494,677 $6.46 $6.49 $6.42
    10 Oct 2024 $6.46 $0.11 1.73% 1,926,671 $6.37 $6.57 $6.33
    09 Oct 2024 $6.35 $0.00 0.00% 1,335,940 $6.30 $6.40 $6.27
    08 Oct 2024 $6.35 $-0.02 -0.31% 3,200,078 $6.33 $6.52 $6.19
    07 Oct 2024 $6.37 $0.14 2.25% 979,318 $6.24 $6.40 $6.23
    04 Oct 2024 $6.23 $-0.09 -1.42% 1,089,762 $6.30 $6.31 $6.17
    03 Oct 2024 $6.32 $-0.09 -1.40% 2,219,963 $6.33 $6.38 $6.24
    02 Oct 2024 $6.41 $0.18 2.89% 3,376,613 $6.20 $6.49 $6.19

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Aug 2024 David Bortolussi Buy 490,906 $2,744,164
    Conversion of securities.
    30 Aug 2024 David Bortolussi Exercise 490,906 $2,744,164
    Conversion of securities. 1,191,246 performance rights
    15 Dec 2023 David Bortolussi Issued 690,066 $2,794,767
    Issue of securities. 1,682,152 performance rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Warwick Lynton Every-Burns Non-Executive Director Aug 2016
    Mr Every-Burns has been a career Consumer Packaged Goods (CPG) executive of global scale. His executive roles have included a career with The Clorox Company of the USA as Senior Vice President, International, based in the USA and prior to that as VP Asia Pacific. His earlier roles included Managing Director of NationalPak Limited (the Glad Products Company ultimately acquired by Clorox) and a long career with Unilever plc where he was based in Australia. He is also Chair of the People and Remuneration Committee.
    Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
    Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
    Ms Philippa (Pip) Mary Greenwood Non-Executive Director Jul 2019
    Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
    Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
    Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
    Ms Sandra Yu Non-Executive Director Mar 2022
    Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
    Mr David Wang Non-Executive Director Sep 2022
    Mr Wang brings expertise across the Asia-Pacific region in manufacturing and supply chain with over 30 years of experience in industrial and consumer goods businesses including 15 years in senior executive leadership roles in China and international. In his career, David has held various senior executive roles including at Blackstone AVINTIV Inc and Dover Corporation where his responsibilities covered manufacturing, research and development, technology, sales and marketing throughout Asia. David sits on both the Risk Management and the People and Remuneration Committees.
    Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
    -
    Jaron McVicar Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 113,290,528 15.67%
    Citicorp Nominees Pty Limited 96,163,814 13.30%
    BNP Paribas Nominees NZ Limited Bpss40* 42,529,528 5.88%
    J P Morgan Nominees Australia Pty Limited 34,661,044 4.79%
    HSBC Nominees (New Zealand) Limited* 26,156,306 3.62%
    Tea Custodians Limited* 21,013,734 2.91%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 20,980,543 2.90%
    Accident Compensation Corporation* 20,509,205 2.84%
    JPMORGAN Chase Bank* 18,595,095 2.57%
    New Zealand Superannuation Fund Nominees Limited* 17,659,815 2.44%
    Citibank Nominees (NZ) Ltd* 15,787,511 2.18%
    New Zealand Depository Nominee 14,021,429 1.94%
    National Nominees Limited 13,425,469 1.86%
    HSBC Nominees (New Zealand) Limited* i 9,463,432 1.31%
    Premier Nominees Limited* 8,473,699 1.17%
    Public Trust* 7,323,398 1.01%
    UBS Nominees Pty Ltd 6,938,917 0.96%
    New Zealand Permanent Trustees Limited* 6,325,699 0.88%
    BNP Paribas Noms Pty Ltd 6,123,304 0.85%
    JBWere (NZ) Nominees Limited 5,945,531 0.82%

    Profile

    since

    Note